Tripartite motif-containing protein 30 modulates TCR-activated proliferation and effector functions in CD4+ T cells

PLoS One. 2014 Apr 22;9(4):e95805. doi: 10.1371/journal.pone.0095805. eCollection 2014.

Abstract

To avoid excessive activation, immune signals are tightly controlled by diverse inhibitory proteins. TRIM30, a tripartite motif (TRIM)-containing protein is one of such inhibitors known to function in macrophages. To define the roles of TRIM30, we generated Trim30 knockout (Trim30-/-) mice. Trim30 deletion caused no major developmental defects in any organs, nor showed any discernable defect in the activation of macrophages. But, Trim30-/- mice showed increased CD4/CD8 ratio when aged and Trim30-/- CD4+ T cells exhibited an abnormal response upon TCR activation, in particular in the absence of a costimulatory signal. Adoptive transfer of wild-type and Trim30-/- CD4+ T cells together into lymphopenic hosts confirmed higher proliferation of the Trim30-/- CD4+ T cells in vivo. Despite the enhanced proliferation, Trim30-/- T cells showed decreased levels of NF-κB activation and IL-2 production compared to wild-type cells. These results indicate a distinct requirement for TRIM30 in modulation of NF-κB activation and cell proliferation induced by TCR stimulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • CD4-CD8 Ratio
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / metabolism*
  • Carrier Proteins / genetics*
  • Carrier Proteins / metabolism
  • Cell Cycle / genetics
  • Homeodomain Proteins / genetics
  • Lymphocyte Activation / genetics*
  • Lymphocyte Activation / immunology*
  • Male
  • Mice
  • Mice, Knockout
  • NF-kappa B / metabolism
  • Receptors, Antigen, T-Cell / metabolism*

Substances

  • Carrier Proteins
  • Homeodomain Proteins
  • NF-kappa B
  • Receptors, Antigen, T-Cell
  • TRIM3 protein, mouse
  • RAG-1 protein

Grants and funding

This research was supported by the Global Research Laboratory Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (MEST; K20705000006-12A0500-00610 to Y.-J.K.), the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (MEST; 2012028272 to Y.-J.K.), the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI13C08470200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.